Relative value of race, family history and prostate specific antigen as indications for early initiation of prostate cancer screening

Journal of Urology

Volumn 192, Issue 3, 2014, Pages 724-729

  Vertosick, Emily A ^a   Poon, Bing Ying ^a   Vickers, Andrew J ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

African Americans; age factors; prostate specific antigen; prostatic neoplasms; risk

Indexed keywords

PROSTATE SPECIFIC ANTIGEN; PROSTATE ANTIGEN;

ADULT; AFRICAN AMERICAN; ARTICLE; BLACK PERSON; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; CANCER SCREENING; CONTROLLED STUDY; FAMILY HISTORY; FIRST DEGREE RELATIVE; GROUPS BY AGE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIORITY JOURNAL; PROSTATE CANCER; RACE; RISK ASSESSMENT; CANCER DIAGNOSIS; COMPARATIVE STUDY; HIGH RISK POPULATION; PREDICTIVE VALUE; SENSITIVITY ANALYSIS; UNITED STATES;

AFRICAN AMERICANS; AGE FACTORS; PROSTATE SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RISK;

AFRICAN AMERICANS; EARLY DETECTION OF CANCER; HUMANS; MALE; MIDDLE AGED; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RISK ASSESSMENT;

EID: 84906077049     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2014.03.032     Document Type: Article

References (25)

1. F.H. Schroder, J. Hugosson, and M.J. Roobol et al. Screening and prostate-cancer mortality in a randomized European study N Engl J Med 360 2009 1320
2. H.B. Carter, P.C. Albertsen, and M.J. Barry et al. Early detection of prostate cancer: AUA Guideline J Urol 190 2013 419
3. M.H. Kawachi, R.R. Bahnson, and M. Barry et al. NCCN clinical practice guidelines in oncology: prostate cancer early detection J Natl Compr Canc Netw 8 2010 240
4. A.M. Wolf, R.C. Wender, and R.B. Etzioni et al. American Cancer Society guideline for the early detection of prostate cancer: update 2010 CA Cancer J Clin 60 2010 70
5. NPS Medicinewise: Health News and Evidence: Should You Routinely Test Your Patients for Prostate Cancer? Available at http://www.nps.org.au/health- professionals/health-news-evidence/2013/test-for-prostate-cancer. Accessed January 2014.
6. Cancer Research UK: CancerHelp: Screening for Prostate Cancer. Available at http://www.cancerresearchuk.org/cancer-help/type/prostate-cancer/about/ screening-for-prostate-cancer. Accessed January 2014.
7. S. Loeb, H.B. Carter, and W.J. Catalona et al. Baseline prostate-specific antigen testing at a young age Eur Urol 61 2012 1
8. A.J. Vickers, D. Ulmert, and D.D. Sjoberg et al. Strategy for detection of prostate cancer based on relation between prostate specific antigen at age 40-55 and long term risk of metastasis: case-control study BMJ 346 2013 f2023
9. H. Lilja, D. Ulmert, and T. Bjork et al. Long-term prediction of prostate cancer up to 25 years before diagnosis of prostate cancer using prostate kallikreins measured at age 44 to 50 years J Clin Oncol 25 2007 431
10. D. Ulmert, A.M. Cronin, and T. Bjork et al. Prostate-specific antigen at or before age 50 as a predictor of advanced prostate cancer diagnosed up to 25 years later: a case-control study BMC Med 6 2008 6
11. M. Saraiya, B.J. Kottiri, and S. Leadbetter et al. Total and percent free prostate-specific antigen levels among U.S. men, 2001-2002 Cancer Epidemiol Biomarkers Prev 14 2005 2178
12. S. Rastogi, T.D. Johnson, and E.M. Hoeffel et al. 2010 Census Briefs: The Black Population: 2010 2011 U.S. Department of Commerce Washington, D.C.
13. National Cancer Institute: Overview of the SEER Program. Available at http://seer.cancer.gov/about/overview.html. Accessed January 2014.
14. S.D. Ramsey, P. Yoon, and R. Moonesinghe et al. Population-based study of the prevalence of family history of cancer: implications for cancer screening and prevention Genet Med 8 2006 571
15. P.L. Mai, L. Wideroff, and M.H. Greene et al. Prevalence of family history of breast, colorectal, prostate, and lung cancer in a population-based study Public Health Genomics 13 2010 495
16. P.F. Pinsky, B.S. Kramer, and D. Reding et al. Reported family history of cancer in the prostate, lung, colorectal, and ovarian cancer screening trial Am J Epidemiol 157 2003 792
17. C. Rodriguez, E.E. Calle, and H.L. Miracle-McMahill et al. Family history and risk of fatal prostate cancer Epidemiology 8 1997 653
18. A. Brandt, J.L. Bermejo, and J. Sundquist et al. Age-specific risk of incident prostate cancer and risk of death from prostate cancer defined by the number of affected family members Eur Urol 58 2010 275
19. A. Brandt, J. Sundquist, and K. Hemminki Risk for incident and fatal prostate cancer in men with a family history of any incident and fatal cancer Ann Oncol 23 2012 251
20. SEER Cancer Statistics Factsheets: Prostate Cancer. Available at http://seer.cancer.gov/statfacts/html/prost.html. Accessed January 2014.
21. C.J. Savage, H. Lilja, and A.M. Cronin et al. Empirical estimates of the lead time distribution for prostate cancer based on two independent representative cohorts of men not subject to prostate-specific antigen screening Cancer Epidemiol Biomarkers Prev 19 2010 1201
22. Social Security Administration: Actuarial Life Tables - Period Life Table, 2009. Available at http://www.ssa.gov/oact/STATS/table4c6.html. Accessed January 2014.
23. T.O. Morgan, S.J. Jacobsen, and W.F. McCarthy et al. Age-specific reference ranges for prostate-specific antigen in black men N Engl J Med 335 1996 304
24. V.N. Giri, B. Egleston, and K. Ruth et al. Race, genetic West African ancestry, and prostate cancer prediction by prostate-specific antigen in prospectively screened high-risk men Cancer Prev Res (Phila) 2 2009 244
25. D.M. Mondo, K.A. Roehl, and S. Loeb et al. Which is the most important risk factor for prostate cancer: race, family history, or baseline PSA level? J Urol 179 2008 148